Distinct down-regulation of cardiac ?1- and ?2-adrenoceptors in different human heart diseases
- 1 February 1991
- journal article
- Published by Springer Nature in Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie
- Vol. 343 (2) , 217-220
- https://doi.org/10.1007/bf00168613
Abstract
Cardiac β-adrenoceptor density and β1- and β2-subtype distribution were examined in human left ventricular myocardium from transplant donors serving as controls and from patients with mitral valve stenosis, aortic valve stenosis, idiopathic dilated cardiomyopathy, and ischaemic cardiomyopathy respectively. The total β-adrenoceptor density was similar in transplant donors and patients with moderate heart failure (NYHA II–III) due to mitral valve stenosis, but was markedly reduced in all forms of severe heart failure (NYHA III–IV) studied. A reduction of both β1- and β2-adrenoceptors was found in patients with severe heart failure due to mitral valve stenosis or ischaemic cardiomyopathy. In contrast, a selective down-regulation of β1-adrenoceptors with unchanged β2-adrenoceptors and hence a relative increase in the latter was observed in idiopathic dilated cardiomyopathy and aortic valve stenosis. It is concluded that the extent of total β-adrenoceptor down-regulation is related to the degree of heart failure. Selective loss of β1-adrenoceptors is not specific for idiopathic dilated cardiomyopathy but also occurs in aortic valve stenosis. Changes in β1- and β2-subtype distribution are rather related to the aetiology than to the clinical degree of heart failure.Keywords
This publication has 20 references indexed in Scilit:
- Reduced Effects of Dopexamine on Force of Contraction in the Failing Human Heart Despite Preserved β2-Adrenoceptor SubpopulationJournal of Cardiovascular Pharmacology, 1989
- Myocardial beta-adrenoceptor changes in heart failure: concomitant reduction in beta,- and beta2-adrenoceptor function related to the degree of heart failure in patients with mitral valve diseaseJournal of the American College of Cardiology, 1989
- Basal and Isoprenaline-Stimulated cAMP Content in Failing Versus Nonfailing Human Cardiac PreparationsJournal of Cardiovascular Pharmacology, 1989
- Drug- and disease-induced changes of human cardiac 1- and 2-adrenoceptorsEuropean Heart Journal, 1989
- Characterization and autoradiographic localization of β‐adrenoceptor subtypes in human cardiac tissuesBritish Journal of Pharmacology, 1987
- Regional Distribution of β-Adrenoceptors in the Human HeartJournal of Cardiovascular Pharmacology, 1986
- Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure.Circulation Research, 1986
- $beta;-Adrenergic function in heart muscle disease and heart failureJournal of Molecular and Cellular Cardiology, 1985
- Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart FailureNew England Journal of Medicine, 1984
- Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human HeartsNew England Journal of Medicine, 1982